Cell News and Research

RSS

hUCBs and MenSCs transplant may offer future therapeutic benefit for AD, stroke, ALS

Transplanting stem cells derived from umbilical cord blood cells and menstrual blood cells may offer future therapeutic benefit for those suffering from stroke, Alzheimer's disease, and amyotrophic lateral sclerosis, says a team of neuroscience researchers from the University of South Florida's Department of Neurosurgery and Brain Repair and collaborators from three private-sector research groups, Saneron CCEL Therapeutics, Inc., Tampa, FL, Cryo-Cell International, Inc., Oldsmar, FL, and Cryopraxis, Cell Praxis, BioRio, Rio de Janeiro, Brazil.

8 Mar 2011

New discovery can provide insight into lung cancer

A discovery at University of Colorado Cancer Center shows testing lung cancer on a molecular level can produce new insights into this deadly disease.

8 Mar 2011

New study reveals role of INK4, ARF proteins in Burkitt's lymphoma

Burkitt's lymphoma is one of the most aggressive tumors affecting humans. Multiple alterations in genes that regulate cell proliferation rate explain its aggressive behavior.

8 Mar 2011

Alliqua completes transdermal pain patch initial in vitro study for treatment of PHN

Alliqua, Inc., an advanced biomedical products company focused on the development and manufacturing of proprietary drug delivery and liver health technologies, announced today the successful completion of its initial in vitro permeation study for its transdermal pain patch project.

8 Mar 2011

Ambry, RainDance enter new collaboration to develop and commercialize ADME screening

RainDance Technologies, Inc. and Ambry Genetics, today announced a new collaboration focused on the development and commercialization of a comprehensive drug absorption, distribution, metabolism, and excretion genetic screening panel for use on next-generation sequencing systems.

8 Mar 2011

Elsevier offers Arabic bilingual medical texts to major universities in the Middle East

Elsevier, the leading global publisher of scientific, technical, and medical information products and services, announced today it has begun offering Arabic bilingual editions of leading Elsevier medical texts to major universities in the Middle East. The first order was recently received by Kalamoon University in Syria.

7 Mar 2011

Solasia, ZIOPHARM enter license and collaboration agreement for darinaparsin product

ZIOPHARM Oncology, Inc., an oncology small molecule and synthetic biology drug development company, and Solasia Pharma K.K., a developer of Western oncology pharmaceuticals in-licensed for commercialization in Asian markets, announced today that they have entered into a license and collaboration agreement to develop and commercialize ZIOPHARM's darinaparsin product and related organic arsenic molecules in specified Pan-Asian/Pacific territories.

7 Mar 2011

NanoLogix announces MRSA testing preliminary results, new Science Advisory Board members at UTHSC

NanoLogix, a biotechnology innovator in the rapid detection and identification of live-cell microorganisms, announces preliminary results of MRSA testing at the University of Texas Health Science Center - Houston. Dr. Jonathan Faro, M.D., Ph.D. has found NanoLogix technology is able to deliver results for MRSA in 6 hours, as opposed to conventional culture-based testing wait times of 24 to 48 hours.

7 Mar 2011

Inovio initiates VGX-3100 Phase II trial in patients with cervical cancer

Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that it is initiating a Phase II clinical trial for its VGX-3100 DNA vaccine for cervical dysplasia and cancer caused by human papillomavirus.

7 Mar 2011

USPTO grants patent to Symphogen's Sym004 to treat solid tumors

Symphogen, a private biopharmaceutical company developing superior antibody therapeutics, said the company had been granted a US patent for Sym004 as well as other antibody compositions containing at least two distinct anti-EGFR antibodies having certain binding characteristics.

7 Mar 2011

Poll explores link between Americans' use of communication technologies and sleep habits

The 2011 Sleep in America- poll released today by the National Sleep Foundation finds pervasive use of communications technology in the hour before bed. It also finds that a significant number of Americans aren't getting the sleep they say they need and are searching for ways to cope.

7 Mar 2011

New study unmasks molecule that can protect against epileptic seizure

For years brain scientists have puzzled over the shadowy role played by the molecule putrescine, which always seems to be present in the brain following an epileptic seizure, but without a clear indication whether it was there to exacerbate brain damage that follows a seizure or protect the brain from it. A new Brown University study unmasks the molecule as squarely on the side of good: It seems to protect against seizures hours later.

6 Mar 2011

Scientists identify regulatory T cells responsible for limiting immune response

Scientists from the Walter and Eliza Hall Institute have identified the key immune cell population responsible for regulating the body's immune response.

6 Mar 2011

NCRM, CSCRM to become national force in regenerative medicine

In a move to streamline and accelerate the research and development of new stem cell and regenerative medicine technologies, the National Center for Regenerative Medicine and the Center for Stem Cell and Regenerative Medicine at Case Western Reserve University have been rolled into a single entity housed within the university's School of Medicine.

5 Mar 2011

Elsevier / Gold Standard announces enhancements to ProspectoRx

Elsevier / Gold Standard, a leading developer of drug databases and medication management solutions, announced today several enhancements to its pricing tool, ProspectoRx, including the addition of Federal Supply Schedule pricing to facilitate pricing analysis.

5 Mar 2011

Dr Russell Wallis, Reader and RCUK Academic Fellow to give Frank May Prize Lecture 2010

The Frank May Prize Lecture 2010, entitled 'Fishing for Complement: innate targeting of microbial pathogens', will be given by Dr Russell Wallis, Reader and RCUK Academic Fellow in the Department of Infection, Immunity and Inflammation, and Department of Biochemistry.

5 Mar 2011

DIR's 'Carnival for a Cure' program to discuss about life with diabetes

Hundreds of families have come to expect a whirlwind of surprises at the always-entertaining Carnival for a Cure, benefiting the Diabetes Research Institute. At this year's 6th annual affair, to be held on Sunday, March 13, 2011 from 1 p.m. to 4 p.m. at the Metropolitan Pavilion located at 125 W. 18th St., guests will enjoy a special appearance by Nick Jonas, who will talk about life with diabetes during the program.

5 Mar 2011

CDI announces publication of footprint-free iPSCs production method in PLoS ONE journal

Cellular Dynamics International, the world's largest producer of human tissue cells for drug discovery and safety testing, today announced the publication of research demonstrating an efficient and scalable method of creating DNA integration-free, or footprint-free, induced pluripotent stem cells under a feeder-free condition using chemically defined media.

5 Mar 2011

FDA approves change to prescribing information for Gilead Sciences' Letairis

Gilead Sciences, Inc. today announced that the U.S. Food and Drug Administration has approved a change to the prescribing information for Letairis (ambrisentan 5 mg and 10 mg tablets), the company's once-daily treatment to improve exercise ability and delay clinical worsening in pulmonary arterial hypertension (PAH, WHO Group 1) patients with predominantly WHO Functional Class II-III symptoms.

5 Mar 2011

NFBI to hold seminar on everyday tips and techniques for blind people in Burlington

The National Federation of the Blind of Iowa, Iowa's largest consumer group of blind people, will hold its third technology seminar titled "Independence Is Easy -- Do You Know What I Know?" on Saturday, March 12. The seminar will be held at the Comfort Suites in Burlington.

5 Mar 2011

Cell News and Research

hUCBs and MenSCs transplant may offer future therapeutic benefit for AD, stroke, ALS

New discovery can provide insight into lung cancer

New study reveals role of INK4, ARF proteins in Burkitt's lymphoma

Alliqua completes transdermal pain patch initial in vitro study for treatment of PHN

Ambry, RainDance enter new collaboration to develop and commercialize ADME screening

Elsevier offers Arabic bilingual medical texts to major universities in the Middle East

Solasia, ZIOPHARM enter license and collaboration agreement for darinaparsin product

NanoLogix announces MRSA testing preliminary results, new Science Advisory Board members at UTHSC

Inovio initiates VGX-3100 Phase II trial in patients with cervical cancer

USPTO grants patent to Symphogen's Sym004 to treat solid tumors

Poll explores link between Americans' use of communication technologies and sleep habits

New study unmasks molecule that can protect against epileptic seizure

Scientists identify regulatory T cells responsible for limiting immune response

NCRM, CSCRM to become national force in regenerative medicine

Elsevier / Gold Standard announces enhancements to ProspectoRx

Dr Russell Wallis, Reader and RCUK Academic Fellow to give Frank May Prize Lecture 2010

DIR's 'Carnival for a Cure' program to discuss about life with diabetes

CDI announces publication of footprint-free iPSCs production method in PLoS ONE journal

FDA approves change to prescribing information for Gilead Sciences' Letairis

NFBI to hold seminar on everyday tips and techniques for blind people in Burlington

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest Life Science News